Skip to main content

Advertisement

Open Peer Review Reports for: S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Jul 2013 Submitted Original manuscript
13 Oct 2013 Reviewed Reviewer Report - In Hae Park
14 Oct 2013 Reviewed Reviewer Report - Rami Haddad
3 Nov 2013 Author responded Author comments - Yong Wha Moon
Resubmission - Version 2
3 Nov 2013 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
14 Nov 2013 Author responded Author comments - Yong Wha Moon
Resubmission - Version 4
14 Nov 2013 Submitted Manuscript version 4
Publishing
2 Dec 2013 Editorially accepted
6 Dec 2013 Article published 10.1186/1471-2407-13-583

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement